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Abstract
Recent global malaria burden modeling efforts have produced significantly different estimates, particularly in adult malaria
mortality. To measure malaria control progress, accurate malaria burden estimates across age groups are necessary. We
determined age-specific malaria mortality rates in western Kenya to compare with recent global estimates. We collected
data from 148,000 persons in a health and demographic surveillance system from 2003–2010. Standardized verbal autopsies
were conducted for all deaths; probable cause of death was assigned using the InterVA-4 model. Annual malaria mortality
rates per 1,000 person-years were generated by age group. Trends were analyzed using Poisson regression. From 2003–
2010, in children ,5 years the malaria mortality rate decreased from 13.2 to 3.7 per 1,000 person-years; the declines were
greatest in the first three years of life. In children 5–14 years, the malaria mortality rate remained stable at 0.5 per 1,000
person-years. In persons $15 years, the malaria mortality rate decreased from 1.5 to 0.4 per 1,000 person-years. The malaria
mortality rates in young children and persons aged $15 years decreased dramatically from 2003–2010 in western Kenya,
but rates in older children have not declined. Sharp declines in some age groups likely reflect the national scale up of
malaria control interventions and rapid expansion of HIV prevention services. These data highlight the importance of age-
specific malaria mortality ascertainment and support current strategies to include all age groups in malaria control
interventions.
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Introduction
During the past decade, malaria control interventions have been
scaled up in Kenya and across sub-Saharan Africa. Accurate
malaria burden estimates across time and age groups are necessary
to measure progress and to focus programmatic interventions.
Recent malaria burden estimates using different modeling
approaches have led to different and controversial results,
particularly in adults [1–5]. Murray and colleagues’ findings,
based in part on verbal autopsy estimates, suggest that the global
proportion of malaria deaths in adults is almost always more than
40%, which is much higher than previous estimates of 10%
[2,3,5].
Since 2001, the Kenya Medical Research Institute (KEMRI)
and the U.S. Centers for Disease Control and Prevention (CDC)
have monitored malaria mortality as part of the KEMRI/CDC
Health and Demographic Surveillance System (HDSS) in rural
western Kenya, as described in detail elsewhere [6]. The KEMRI/
CDC HDSS is located in the malaria-endemic lake region of
western Kenya. The region is characterized by high Plasmodium
falciparum parasite prevalence (i.e., 38% in children ,15 years in
2010) and sustained high HIV prevalence (i.e., 15% in persons .
15 years from 2007–2012) [7–9]. The region has relatively high
household insecticide-treated net ownership (i.e., 60%) but lower
use estimates (i.e., 38% overall and 48% for children ,5 years of
age) [7]. The KEMRI/CDC HDSS has higher household
insecticide-treated net ownership at 81% and usage of 57%
overall and 65% for children ,5 years of age [KEMRI/CDC,
unpublished data]. We analyzed KEMRI/CDC HDSS data to
determine the changes in malaria-specific mortality rates (MMR)
and the proportion of malaria deaths across age groups from
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2003–2010 and to compare these data with recent global
estimates.
Methods
Ethics Statement
The protocol for the KEMRI/CDC HDSS was approved by
the institutional review boards of KEMRI (# 1801, Nairobi,
Kenya) and CDC (# 3308, Atlanta, GA). Following cultural
customs, the compound head provided informed written consent
for all compound members, including children, to participate in
KEMRI/CDC HDSS activities. Any individual could refuse to
participate at any time by verbal request. The KEMRI/CDC
HDSS protocol and consent procedures, including surveillance
and verbal autopsy, are approved by both KEMRI and CDC
institutional review boards annually.
Data were obtained from two contiguous areas of the KEMRI/
CDC HDSS, Asembo and Gem districts in Siaya County, from
2003–2010 [6]. The combined population of the areas was
147,988; 16% were children ,5 years of age [10]. Malaria
transmission is perennially high with peaks in May–July and
October–November coinciding with the end of seasonal rains. All
residences in the KEMRI/CDC HDSS were visited every four
months by program staff; detailed methods previously have been
reported [6,11]. Deaths were captured through two systems:
during home surveillance visits by program staff every four months
and through continuous reporting by community interviewers,
with ID linkage to prevent double reporting. Following a one-
month grieving period, standardized verbal autopsy questionnaires
were administered [6].
Verbal autopsy data were interpreted using the InterVA model
version 4.RC1 (InterVA-4) [12]. InterVA-4 is a probabilistic
mathematical model based on Bayesian theory used to determine
cause-specific mortality fractions from standardized verbal autopsy
findings [12,13]. The InterVA-4 model allows for input of
epidemiological parameters for both malaria and HIV/AIDS. In
the KEMRI/CDC HDSS, both malaria and HIV/AIDS account
for more than 1% of all deaths in the population and are
considered ‘‘high’’ prevalence in the model. Conceptually, the
model interprets deaths similar to the way a physician would,
knowing that (s)he is working in a population with high malaria
and HIV/AIDS prevalence [12].
Annual MMR per 1,000 person-years (PY) were generated, and
the analyses were categorized by three age groups: children ,5
years, children 5–14 years, and persons $15 years. The latter two
age groups were collapsed into a fouth category, persons $5 years
of age, for comparison with other estimates using only two age
categories. Rates were also disaggregated by year for children ,15
years. Changes in malaria mortality from 2003–2010 were
analyzed by Poisson regression linear test for trend; 95%
confidence intervals were calculated around rates using the PEPI
(i.e., acronym for Programs for EPIdemiologists) utility for crude
rates [14]. Analysis was performed using SAS version 9.1 (SAS
Institute, Cary, NC) and Stata 12 (StataCorp, College Station,
TX).
Results
The total number of deaths due to malaria in the population of
the KEMRI/CDC HDSS decreased from 421 per year in 2003 to
140 per year in 2010, a three-fold reduction (Table 1). During the
same period, the overall MMR decreased from 3.1 to 1.0 per
1,000 PY (p,0.0001). In children ,5 years, the MMR decreased T
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from 13.2 to 3.7 per 1,000 PY, a mean reduction of 20% annually
from 2003 to 2010 (p,0.0001).
The MMR declined sharply among infants, aged 0 to ,12
months, from 45.8 to 0.4 per 1000 PY (p,0.0001). Declines were
also evident for children during their second year of life (i.e., aged
12 months to ,24 months) decreasing from 19.9 to 10.0 (p,
0.0001) and third year of life (i.e., aged 24 months to ,36 months)
decreasing from 10.1 to 6.6 per 1000 PY (p= 0.0002). The MMR
increased among children aged 3 to 5 years from 2003–2010,
although the change in rates were not statistically significant
(Figure 1).
In children 5–14 years, the MMR remained relatively stable
over the study period at 0.5 per 1,000 PY, with rates in 2010
mirroring rates in 2003. In this age group, annual rates by age in
years fluctuated with no significant trends observed. In persons $
15 years, the MMR decreased from 1.5 to 0.4 per 1,000 PY for a
mean reduction of 20% annually (p,0.0001). When divided into
only two age categories, the MMR for persons $5 years decreased
from 1.1 to 0.4 per 1,000 PY for a mean reduction of 17%
annually (p,0.0001).
From 2003 to 2010, the proportion of all malaria deaths by age
group decreased in children,5 years from 70% to 61%, increased
in children 5–14 years from 4% to 14%, and decreased slightly in
persons $15 years from 26% to 24% (Figure 2). When divided
into two age categories, the proportion of all malaria deaths in
persons $5 years increased from 30% in 2003 to 39% in 2010.
From 2003 to 2010, the proportion of malaria deaths among all
deaths decreased in children ,5 years from 29% to 16%,
increased in children 5–14 years from 16% to 21%, and decreased
in individuals $15 years from 6% to 3% (Figure 3). When divided
into two age categories, the proportion of malaria deaths in
persons $5 years decreased from 9% to 5%.
Discussion
Data from the KEMRI/CDC HDSS demonstrate the substan-
tial progress made since 2003 in reducing malaria mortality in
western Kenya. The 2004 peak of malaria mortality in western
Kenya coincides with the global malaria mortality trends
described in the 2011 World Malaria Report and Murray and
colleagues’ estimates for sub-Saharan Africa [3,5]. The accelerat-
ing trend of declining malaria mortality among children ,5 years
since 2003 is also consistent with the declining trend in all-cause
mortality among children ,5 years in sub-Saharan Africa since
2000 [15]. The MMRs in young children and persons $15 years
have decreased dramatically from 2003 to 2010.
The MMR in children aged 5–14 years has not declined
concurrently, and malaria as a proportion of all-cause mortality
increased over the study period in this age group. Because the
absolute number of deaths and the MMR remained relatively
unchanged across the study period, the increase is probably not
due to delayed acquisition of immunity. The lack of a concomitant
decline in MMR in this age group might be attributed to older
children not having been targeted for malaria programmatic
interventions in most countries, including Kenya. Data from the
KEMRI/CDC HDSS, for example, indicate that insecticide-
treated net use was lowest in the 5–14 year-old age group (43%
usage), and the 58% P. falciparum parasite prevalence in this age
group was higher than all other age groups [KEMRI/CDC,
unpublished data].
These data provide insight into a shift of mortality burden from
infants to slightly older children who, as discussed above, do not
seem to have benefited as much as younger children from malaria
intervention. Continued mortality surveillance is needed to
ascertain if deaths in older children proportionately increase, or
increase in absolute terms, as malaria transmission is reduced
towards pre-elimination levels, as suggested in the literature
[16,17]. In order to reach global malaria control and elimination
goals, interventions will have to be scaled up in age groups that
historically have been excluded and surveillance strengthened
across all age groups to monitor impact [18].
The considerable decline in MMRs in the KEMRI/CDC
HDSS likely reflects, in part [19], the growth of malaria and HIV
interventions in Kenya over the study period. For malaria, the
introduction and scale up of key interventions recommended by
Roll Back Malaria occurred during the study period [20]. In 2004,
Kenya changed the national malaria treatment policy to
Figure 1. Malaria mortality rates per 1,000 person-years by age and study year. Note: x-axis indicates stacked (not aggregate) rates.
doi:10.1371/journal.pone.0106197.g001
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recommend artemisinin-based combination therapy (ACT) as the
first-line treatment for uncomplicated malaria, and by 2006, the
new ACT guidelines were implemented countrywide [21,22].
However, by 2010, only 18% of febrile children ,5 years were
treated with an ACT for uncomplicated malaria, suggesting that
most malaria cases were being treated with ineffective medications
or monotherapies throughout the study period [7]. Kenya did not
adopt national policy to introduce malaria rapid diagnostic tests
(RDTs) in endemic areas until 2012. Therefore, the majority of
treatment for malaria during the study period was likely based on
clinical diagnosis. The national malaria control program targeted 3.4
million children,5 years during the first mass insecticide-treated net
Figure 2. Trend in the proportion of malaria mortality by age group.
doi:10.1371/journal.pone.0106197.g002
Figure 3. Malaria mortality as a proportion of all-cause mortality by age group.
doi:10.1371/journal.pone.0106197.g003
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campaign in 2006 and conducted a second mass net campaign in
2010–2011 to provide universal coverage in malaria endemic and
epidemic-prone areas. The mass campaigns increased net use by
children,5 years from 4.6% in 2003 to 42.2% in 2010 [7,23]. Since
1998, the national malaria control program has recommended
intermittent preventive therapy for pregnant women, and by 2010,
25% of women received two or more doses of sulphadoxine-
pyrimethamine during pregnancy compared to 13% in 2007 [7].
Additionally, the expansion of HIV prevention, treatment and
care services are likely to have significantly contributed to the gains
achieved in mortality reduction, particularly among the youngest
children. Before 2003, most Kenyans had no access to HIV
services, but by 2008, 1 in 5 HIV-positive adults were receiving
HIV care, with half of those eligible receiving antiretroviral
therapy [24]. A South African study found that for every 100 HIV-
infected persons on antiretroviral therapy, 6.3 fewer deaths
occurred the following year, including among children [25].
Studies in the KEMRI/CDC HDSS showed a halving of all-cause
and HIV-specific mortality among young adult females from 2003
to 2009 [26]. We separately evaluated trends in HIV-specific
mortality rates using the InterVA-4 model; among adults $ 15
years, HIV-specific mortality declined significantly over the study
period (p,0.0001), but among children ,15 years, HIV-specific
mortality by year of age did not show similar trends. Increased
uptake of services to prevent mother-to-child HIV transmission
was likely to have contributed to the particularly dramatic
decrease in malaria-specific mortality among children ,36
months potentially through two mechanisms. First, HIV deaths
in infants and young children were likely to have been misclassified
as malaria deaths because malaria was both common and more
culturally acceptable. Second, preventing HIV infection led to
fewer infants and young children with severe immunodeficiencies
and the associated higher risk of death from malaria and HIV co-
infection. Therefore, both malaria and HIV prevention and
treatment interventions are likely to have contributed to the
dramatic reductions in MMR in children ,5 years and adults $
15 years.
Malaria mortality as a proportion of total mortality decreased
substantially from 2003 to 2010 in children ,5 years and persons
$15 years. In 2008 among children ,5 years, the proportion of
deaths due to malaria was 12% in the KEMRI/CDC HDSS,
which is lower than both the 2008 estimates of 24% by Murray
and 16% by Black for child deaths due to malaria in Africa [5,27].
Recognizing the limitations of verbal autopsy for assigning cause
of death, we also examined all deaths with the symptom of acute
febrile illness (AFI) before death (Figure S1). Between a third to a
half of all deaths in children,5 years and 5–14 years had an acute
febrile illness, which remained relatively constant over the study
period. Similar to the declines observed in MMR, between 2003
and 2010, overall AFI mortality rate also decreased from 5.4 to 2.1
per 1,000 PY (p,0.001): 23.9 to 9.7 per 1,000 PY (p,0.001) in ,
5 years; 0.8 to 0.7 (p = 0.08) in 5–14 years; and 2.8 to 0.9 (p,
0.001) in $15 years. There was a substantial decline in deaths in
children below 3 years of age. Concurrently, as the number of
deaths with AFI declined, the proportion of deaths ascribed to
malaria in those with AFI rose over time across all age groups
(Table S1). Together, this provides some assurance that malaria as
a cause of death was not being under-estimated over time. Among
persons $15 years in the KEMRI/CDC HDSS in 2010, only 3%
of deaths were due to malaria. This percentage is consistent with
recent findings from Byass and colleagues that examined the
distribution of cause-specific mortality across five African countries
using InterVA-4 methodology [28].
The lowest malaria mortality as a proportion of all-cause
mortality occurred in 2008 for persons .5 years and in 2009 for
children ,5 years. The subsequent increase in proportional
malaria mortality in 2009–2010 might have been a result of
internal population displacements due to post-election civil conflict
and wide-scale public sector stock outs of ACTs [11]. Disruption
of health services and population displacement resulting from post-
election violence were identified as factors causing an upsurge in
HIV morbidity and mortality in the KEMRI/CDC HDSS in
2008 [29]. However, the causes of the increase in proportional
malaria mortality might be multifactorial and include natural
variation in cyclical, seasonal, and annual malaria transmission
patterns, linked to weather patterns.
Among all malaria deaths, the proportion that occurred in
individuals ,15 years remained relatively stable at ,75%. We
note the proportion of non-child malaria deaths (,25%) is higher
than the WHO global estimate of 10% and comparable to
estimates for areas with high malaria transmission in Africa by
Murray and colleagues [2,5]. Misclassification bias resulting in the
overestimation of malaria deaths due to HIV-associated mortality
in the early years of the study when HIV-associated mortality
peaked is a potential study limitation [22]. A recent analysis of
cause-specific mortality ratios between HIV-negative and HIV-
positive individuals in five African countries showed that there was
a lower malaria-specific mortality ratio among HIV-positive
individuals than the all-cause mortality ratio associated with
HIV infection [15]. Because cause of death was assigned
consistently over the study period using the InterVA-4 model,
any misclassification bias would be consistent over the study period
and not likely to alter the direction of the change in MMRs.
However, misclassification errors occur in all forms of cause-of-
death assignment, including verbal autopsy with InterVA-4
modeling, and should be recognized in any study relying on
cause-specific mortality data. In particular, misclassification bias
that may differ across ages requires careful validation before the
proportion of age-specific malaria deaths can be reliably estimated
using VA methods.
Conclusions
Substantial gains have been made in malaria prevention and
control in Kenya over the last decade. Data from this study
demonstrates a lower proportion of malaria deaths in children ,5
years compared to other estimates from Africa. For persons $15
years, proportional malaria mortality in 2010 is comparable to
recent estimates for high malaria transmission countries in Africa.
Malaria remains a major public health concern for all age groups,
even in areas of relatively high insecticide-treated net ownership
and use. These data provide some assurance of the potential
contribution current malaria control strategies, such as Roll Back
Malaria strategy of universal coverage with insecticide-treated
nets, may accord and support strategies to reach older children
and adults with malaria prevention and control interventions.
Development and implementation of new malaria surveillance and
control tools to ascertain population groups at risk, including by
age, are necessary for continued progress towards global goals for
malaria control and elimination.
Supporting Information
Figure S1 Acute febrile illness mortality rates per 1,000
person-years by age and study year. Note: x-axis indicates
stacked (not aggregate) rates.
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Table S1 Proportion of malaria deaths out of those with
acute fever, by age and year.
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